Exonhit Announces New Scientific Publications on the Use of SpliceArray™
News Oct 30, 2008
ExonHit Therapeutics S.A. announces the publication of five new key scientific articles based on the use of its owned designed microarrays, SpliceArray™.
“We are excited that the use of ExonHit's microarrays (SpliceArray™ family of products) manufactured on the Agilent Technologies’ and Affymetrix’s microarray platforms, plays an intergral role in these scientific publications. These publications underline the relevance of ExonHit’s approach”, declared Loic Maurel, C.E.O of ExonHit.
“SpliceArray™ can be considered a new standard and a remarkable discovery tool which represents the most complete method to measure the expression of the Human transcriptome, and more recently the Rat transcriptome, in all their diversity. These tools are used by major academic research centers in Europe and the USA as well as by many of the top-tier pharmaceutical and biotechnology companies worldwide. Additionally, ExonHit remains the largest user of these microarrays, particularly within our internal molecular diagnostic discovery programs.”
3-D Printed Sugar Scaffolds Offer Sweet Solution for Tissue EngineeringNews
University of Illinois engineers built a 3-D printer that offers a sweet solution to making detailed structures that commercial 3-D printers can’t: Rather than a layer-upon-layer solid shell, it produces a delicate network of thin ribbons of hardened isomalt, the type of sugar alcohol used to make throat lozenges.READ MORE
3D Printer Developed That Can Create Complex Biological TissuesNews
A UCLA bioengineer has developed a technique that uses a specially adapted 3D printer to build therapeutic biomaterials from multiple materials. The advance could be a step toward on-demand printing of complex artificial tissues for use in transplants and other surgeries.READ MORE
Microfluidic Device Captures Extracellular Vesicles Shed by Brain TumorsNews
Because needle biopsies of brain tumors are invasive and difficult, bioengineers supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed micro-technologies that capture extracellular vesicles (EVs) released by the tumor.READ MORE